相关实验视频

Updated: May 6, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

在Mycobacterium avium和Mycobacterium结核病感染期间对人类巨细胞进行比较的转录组分析

Gül Kilinç¹, Robin H G A van den Biggelaar¹, Tom H M Ottenhoff¹

¹Leiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.

Molecular microbiology

|January 6, 2026

概括

感染Mycobacterium avium (Mav) 的治疗非常困难. 在巨细胞中比较Mav和Mycobacterium结核病 (Mtb) 感染,发现共享和独特的宿主反应,指导新的宿主导向治疗 (HDT) 策略.

科学领域:

免疫学免疫学免疫学
微生物学微生物学
基因组学就是基因组学.

背景情况:

非结核性菌根性肺病主要是由Mycobacterium avium (Mav) 引起的,由于抗生素耐药性,因此存在治疗挑战.
与Mycobacterium tuberculosis (Mtb) 相比,目前对Mav感染中宿主-病原体相互作用的理解有限.
宿主导疗法 (HDT) 通过增强宿主对菌根菌的免疫防御提供了一个有希望的替代方案.

研究的目的:

通过进行全基因组转录组分析来研究宿主对Mav感染的反应.
为了比较Mav诱导的宿主反应与初级人类巨细胞中的Mycobacterium tuberculosis (Mtb) 的反应.
为了确定潜在的HDT目标的共享和Mav特定的宿主途径.

主要方法:

全基因组主机转录基因分析原发性人类巨细胞感染Mav.
与感染Mtb巨细胞的转录组数据进行比较分析.
鉴定和描述差异表达的基因和途径.

主要成果:

观察到Mav和Mtb感染的巨细胞之间的基因表达模式有显著的重叠.
这两种感染都诱导了细胞因子反应和调节的G蛋白合受体 (GPCRs),参与巨细胞的免疫功能.
在直接早期基因 (IEG),合酶和GIMAP家族基因中发现了明显的差异.

结论:

这项研究提供了对Mav感染中宿主-病原体相互作用的基本理解.
确定了共享和Mav特定的途径,为开发新型宿主导疗法 (HDT) 提供了目标.
对比转录组学方法利用Mtb知识来推进Mav感染研究.

更多相关视频

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection

Published on: September 18, 2020

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...